We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Funding Awarded to COVID-19 Clinical Study Targeting Angiotensin Receptor

News   Jun 01, 2020 | Original story from Vicore Pharma

 
Funding Awarded to COVID-19 Clinical Study Targeting Angiotensin Receptor

Credit: rawpixel

 
 
Advertisement
 

RELATED ARTICLES

Oncogene Responsible for Deadly Glioblastoma Identified

News

Scientists have identified an oncogene AVIL responsible for glioblastoma, the deadliest brain tumor. The discovery offers a promising new treatment target.

READ MORE

Robot Jaws Help Test Potential of Chewing Gum As Drug Delivery Method

News

Medicated chewing gum has been recognized as a new advanced drug delivery method but currently, there is no "gold standard" for testing drug release in vitro. Researchers have now designed a chewing robot with built-in humanoid jaws that could aid the development of medicated chewing gum.

READ MORE

Trial Assessing Antiviral Drug DAS181 Against COVID-19 Begins Enrolling Patients

News

Keck Medicine of USC physicians are enrolling patients as part of an international clinical trial, designed to assess the safety and efficacy of the antiviral drug DAS181, as a possible treatment for patients with severe COVID-19.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE